Status | Study |
Active, not recruiting |
Study Name: The Respiratory Protection Effectiveness Clinical Trial Condition: Influenza Respiratory Syncytial Viruses Paramyxoviridae In Date: 2010-11-29 Interventions: Device: N95 Respirator Partici |
Recruiting |
Study Name: Respiratory Virus Hospitalization Study (FLU 003 Plus) Condition: Influenza Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Date: 2010-01-25 |
Completed |
Study Name: A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome Condition: Severe Acute Respiratory Syndrome Date: 2007-12-20 Interventions: Drug: Lopinavir / Ritonavir plus Ribavirin |
Withdrawn |
Study Name: SARS Coronavirus Vaccine (SARS-CoV) Condition: Coronavirus (SARS-CoV) Date: 2007-09-20 Interventions: Drug: Aluminum hydroxide Adjuv |
Withdrawn |
Study Name: SARS Survivor Evaluations Condition: Coronavirus (SARS-CoV) Date: 2007-08-30 |
Completed |
Study Name: Collection of Convalescent SARS Plasma by Apheresis Condition: Severe Acute Respiratory Syndrome SARS Date: 2006-06-19 |
Completed |
Study Name: Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers Condition: Severe Acute Respiratory Syndrome Date: 2005-09-16 Interventions: Drug: Alferon LDO |
Withdrawn |
Study Name: The Interaction Between Severe Acute Respiratory Distress Syndrome Viral Proteins and Monocytes Condition: Severe Acute Respiratory Syndrome Date: 2005-09-12 Interventions: Procedure: blood sampling |
Completed |
Study Name: Dynamic Profiles of Cytokine/Chemokine in Severe Acute Respiratory Syndrome Condition: SARS Date: 2005-09-12 |
Completed |
Study Name: Contamination During Removal of Two Different Personal Protective Systems Condition: Severe Acute Respiratory Syndrome Date: 2005-09-06 Interventions: Procedure: Powered Air purifying respirator |